drugmakers

drugmakers

A bottle of Coldrif cough syrup and a prescription which Reema Yaduvanshi, 26, received from doctor Praveen Soni for her six-month-old son Kartik, in Parasia, Madhya Pradesh, India, 10 October, 2025. Photo: Reuters

India to force drugmakers to upgrade plants after fatal cough syrup crisis

Government tests found the syrup manufactured by Sresan contained 48.6% diethylene glycol (DEG), or nearly 500 times the limit set by India and the WHO.

Representational image

Drugmakers push for swift registration of 1,000 new medicines

Representational image/Collected

Drugmakers take wait-and-see approach amid possible US tariff on pharma imports

Representational image

Renata set to obtain $60m loan from IFC

Top drugmakers log double-digit revenue growth in Jul-Mar

Top drugmakers log double-digit revenue growth in Jul-Mar

Representational image

Drugmakers want to hike prices, citing soaring production costs

A sign stands outside a Bristol Myers Squibb facility in Cambridge, Massachusetts, U.S., May 20, 2021. REUTERS/Brian Snyder

Consumer group says drugmakers abuse US patent system to keep prices high

Top drugmakers keep growth trajectory in H1

Top drugmakers keep growth trajectory in H1

In this March 2021 photo provided by Pfizer, a technician works on a line for packaging preparation for the Pfizer-BioNTech Covid-19 vaccine at the company's facility in Puurs, Belgium. Billions more in profits are at stake for some vaccine makers as the U.S. moves toward dispensing Covid-19 booster shots to shore up Americans' protection against the virus. Photo :AP via UNB

Covid-19 vaccine boosters could mean billions for drugmakers

Production boom for local drugmakers

Production boom for local drugmakers